SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-23-001850
Filing Date
2023-03-29
Accepted
2023-03-28 18:02:21
Documents
54
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K coeptis_i10k-123122.htm   iXBRL 10-K 1428377
2 SUBSIDIARIES OF COEPTIS THERAPEUTICS HOLDINGS, INC. coeptis_ex2101.htm EX-21.1 2099
3 CERTIFICATION coeptis_ex3101.htm EX-31.1 11099
4 CERTIFICATION coeptis_ex3102.htm EX-31.2 11232
5 CERTIFICATION coeptis_ex3201.htm EX-32.1 4999
6 CERTIFICATION coeptis_ex3202.htm EX-32.2 5048
  Complete submission text file 0001683168-23-001850.txt   6361575

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE coep-20221231.xsd EX-101.SCH 40219
8 XBRL CALCULATION FILE coep-20221231_cal.xml EX-101.CAL 49287
9 XBRL DEFINITION FILE coep-20221231_def.xml EX-101.DEF 182427
10 XBRL LABEL FILE coep-20221231_lab.xml EX-101.LAB 299506
11 XBRL PRESENTATION FILE coep-20221231_pre.xml EX-101.PRE 246883
48 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_i10k-123122_htm.xml XML 1044589
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39669 | Film No.: 23771000
SIC: 2836 Biological Products, (No Diagnostic Substances)